COVID-19 pandemic continues to evolve and new variants like Delta and Omicron have been discovered. REGEN-COV is a recombinant human monoclonal antibody to the spike protein of SARS-CoV-2 which received emergency use authorisation for treatment and post-exposure prophylaxis in patients with high risk of progression to severe disease. We review our experience with use of REGEN-COV in paediatric heart transplant patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304944 | PMC |
| http://dx.doi.org/10.1017/S1047951122002190 | DOI Listing |
Publication Analysis
Top Keywords
treatment post-exposure
8
post-exposure prophylaxis
8
regen-cov children
4
children heart
4
heart transplantation
4
transplantation treatment
4
prophylaxis covid-19
4
covid-19 covid-19
4
covid-19 pandemic
4
pandemic continues
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!